Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1351 to 1365 of 2208 results for guidelines

  1. Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis:- A randomised controlled trial should be undertaken to evaluate the clinical and cost effectiveness of stopping intravenous antibiotic therapy and switching to oral therapy within the first 24 hours of treatment in patients with neutropenic sepsis who are having treatment with intravenous antibiotics. The outcomes to be measured are overtreatment, death, need for critical care, length of hospital stay, duration of fever and quality of life.

    treatment at a variety of time points. A meta-regression undertaken by the Guideline Development Group suggested that very early (before...

    Research recommendation
    Published
    9 June 2015

  2. Targeted interventions to support and improve decision-making capacity for treatment:- What is the effectiveness and cost effectiveness of different targeted interventions (speech and language therapy and psychological and psychosocial interventions) to support and improve decision-making capacity for treatment in specific groups?

    the studies were limited in number and generally of low quality. The guideline committee agreed that further research in this area...

    Research recommendation
    Published
    18 December 2018

  3. Radiofrequency denervation:- What is the clinical and cost effectiveness of radiofrequency denervation for chronic low back pain in the long term?

    unreasonable clinical expectation. The economic model presented in this guideline suggested that radiofrequency denervation is likely to...

    Research recommendation
    Published
    13 February 2017

  4. PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)

    NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery .

    Medtech innovation briefing
    Published
    9 February 2021

  5. Indwelling urinary catheters: antibiotic prophylaxis:- When recatheterising patients who have a long-term indwelling urinary catheter, what is the clinical and cost effectiveness of single-dose antibiotic prophylaxis in reducing symptomatic urinary tract infections in patients with a history of urinary tract infections associated with catheter change?

    develop future guidance (the recommendation on this topic in the current guideline was based on GDG consensus). A randomised controlled...

    Research recommendation
    Published
    9 June 2015

  6. Optilume for anterior urethral strictures (MIB241)

    NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures .

    Medtech innovation briefing
    Published
    5 January 2021

  7. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    9 March 2022

  8. Patient self-management plans:- What is the clinical and cost effectiveness of a self-management plan for people with stable angina?

    This research would inform future updates of key recommendations in the guideline. Furthermore the research would be relevant to a...

    Research recommendation
    Published
    9 June 2015

  9. Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs (TA537)

    Evidence-based recommendations on ixekizumab (Taltz) for treating active psoriatic arthritis in adults.

    Technology appraisal guidance
    Published
    8 August 2018
    View recommendations

    Sections for TA537

  10. Ustekinumab for treating moderate to severe plaque psoriasis (TA180)

    Evidence-based recommendations on ustekinumab (Stelara) for treating psoriasis in adults.

    Technology appraisal guidance
    Last updated
    3 March 2017
    View recommendations

    Sections for TA180

  11. t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)

    NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes .

    Medtech innovation briefing
    Published
    22 September 2020

  12. Which of the electronic information-sharing systems perform best for the care of people approaching the end of their life?

    end of their life? Any explanatory notes(if applicable) The guideline committee made recommendations on sharing information about people...

    Research recommendation
    Published
    18 November 2019

  13. Predictors of acute physical risk:- What clinical and biochemical markers are the best predictors of acute physical risk for people with eating disorders?

    nutrition). The medical markers of acute risk are used throughout this guideline. Despite their importance, almost all of the...

    Research recommendation
    Published
    12 October 2018

  14. Hearing loss prevalence in people who under-present for hearing loss:- What is the prevalence of hearing loss among populations who under-present for possible hearingloss?

    consider the possibility of hearing loss.The evidence review for the NICE guideline on adult hearing loss highlighted significant health...

    Research recommendation
    Published
    10 December 2018

  15. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    advocacy as a means of supporting people to make decisions. However, the guideline committee thought that this was an area in which...

    Research recommendation
    Published
    18 December 2018